Biomarker Analysis as a Decision-Making Tool in Drug Discovery and Development: Implications for Peroxisome Proliferator-Activator Receptors

Author： Stoch S. Aubrey   Wagner John A.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.4, 2007-01, pp. : 271-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biospecific Interaction Analysis: A Tool for Drug Discovery and Development

By Gambari R.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-135

Adis International

Access to resources Recommend Favorite

Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 507-512

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator activated receptors and obesity

By Kersten S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 223-234

Elsevier

Access to resources Recommend Favorite

The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes

By  

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

Improving Decision-Making in Drug Development Using In Vitro Toxicology Screening

By Suter Willi  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 347-355

Adis International

Access to resources Recommend Favorite